Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P42574 (caspase-3)
 45,978 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Human immunodeficiency virus (HIV)-1 infection can cause characteristic neural defects such as progressive motor dysfunction, striatal pathology and gliosis. Recent evidence suggests that HIV-induced pathogenesis is exacerbated by heroin abuse and that the synergistic neurotoxicity is a direct effect of heroin on the CNS, an alarming observation considering the high incidence of HIV infection with injection drug abuse. Although HIV infection results in neurodegeneration, neurons themselves are not directly infected. Instead, HIV affects microglia and astroglia, which subsequently contributes to the neurodegenerative changes. Opioid receptors are widely expressed by macroglia and macroglial precursors, and the activation of mu-opioid receptors can modulate programmed cell death, as well as the response of neural cells to cytotoxic insults. For this reason, we questioned whether opioid drugs might modify the vulnerability of macroglia and macroglial precursors to HIV-1 Tat protein. To address this problem, the effects of morphine and/or HIV Tat(1-72) on the viability of macroglia and macroglial precursors were assessed in mixed-glial cultures derived from mouse striatum. Our findings indicate that sustained exposure to morphine and Tat(1-72) viral protein induces the preferential death of glial precursors and some astrocytes. Moreover, the increased cell death is mediated by mu-opioid receptors and accompanied by the activation of caspase-3. Our results imply that opiates can enhance the cytotoxicity of HIV-1 Tat through direct actions on glial precursors and/or astroglia, suggesting novel cellular targets for HIV-opiate interactions.
 ...
PMID:Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. 1521 73

Maternal heroin abuse has been shown to result in teratogenic neurobehavioral defects in the offspring, but the underlying mechanisms remain largely unknown. This study was designed to explore the role of neuronal apoptosis in the heroin-induced neurobehavioral defects of learning and memory. Pregnant BALB/c mice were treated with either heroin or saline. The animals in the heroin group received heroin subcutaneously at a dosage of 10 mg/kg/day on embryonic days (E) 9-18, while those in the saline group were treated as drug-naive. Offspring were grouped as prenatal heroin exposure (HER), prenatal saline exposure (SAL), and control (CON) groups, according to the maternal treatment regimen. Some of the mice were killed and their hippocampus harvested on postnatal day (P) 14, and the tissue subjected to reverse transcription polymerase chain reaction, Western blotting, and immunohistochemistry to reveal the mRNA and protein expressions of caspase-3, Bcl-2, and Bax. The Morris water maze was applied to assess the learning and memory capability of the mice at P30; poor maze performances were observed for the animals in the HER group. The results also showed that the mRNA and protein expressions of caspase-3 and Bax were significantly increased, while that of Bcl-2 was markedly decreased in the HER group compared with both the SAL and CON groups. The immunohistochemistry revealed significant caspase-3 immunoreactivity in the dentate gyrus and cornu ammonis (CA) 1 subareas of the hippocampal formation, whereas, no significant changes were seen in subarea CA3. These findings suggest that prenatal heroin exposure during the E9-18 period enhances neuronal apoptosis by altering the expressions of caspase-3, Bcl-2, and Bax in the mouse hippocampus, and leads to impairment in hippocampus-dependent learning and memory.
 ...
PMID:Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis. 1927 31